Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How
Over the years, a wide variety of therapeutic antibodies has been successfully introduced in the auto-immunology clinic, and many more are on the way. Many of these treatments address either a pathogenic circulating molecule or a cell-bound molecule. Whereas addressing the former target results in n...
Main Authors: | Joyce J.B.C. van Beers, Jan G.M.C. Damoiseaux |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/1/116 |
Similar Items
-
Anticorpos anti-DNase I: nova reatividade sorológica na síndrome de Sjogren primária
by: Griffo, Priscilla
Published: (2018) -
HTLV-I Associated uveitis, myelopathy, rheumatoid arthritis and Sjögren's syndrome Uveite, mielopatia, artrite reumatóide e sindrome de Sjogren associadas ao HTLV-I
by: Sônia Regina A. A. Pinheiro, et al.
Published: (1995-12-01) -
Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome
by: Mana Iizuka-Koga, et al.
Published: (2017-05-01) -
Envolvimento Pulmonar no Síndrome de Sjögren
by: Moura S, et al.
Published: (2016-09-01) -
Sicca Symptoms, Oral Health Conditions, Salivary Flow and Oral <i>Candida</i> in Sjögren’s Syndrome Patients
by: Weini Xin, et al.
Published: (2020-05-01)